ARK Autonomous Technology & Robotics ETF vs ClearPoint Neuro Inc — how do they compare? ARK Autonomous Technology & Robotics ETF trades at $128.09, while ClearPoint Neuro Inc trades at $14.64 (market cap $454.21M). The key difference: ARK Autonomous Technology & Robotics ETF is trading nearer its 52-week high, ClearPoint Neuro Inc nearer its low. Which is the better fit depends on your goals.
| ARKQ | CLPT | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $143.82 | $29.60 |
52-Week Low | $95.28 | $8.66 |
Market Cap | — | $454.21M |
Enterprise Value | — | $488.79M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ClearPoint Neuro (CLPT) trades at $14.56, down slightly by 0.07% today, with a bullish technical signal from moving averages but mixed oscillators. The company reported Q2 2026 revenue growth to $42 million but missed earnings estimates with a loss of $0.38 per share, reflecting ongoing investment in clinical and preclinical services. Despite negative net income margins and cash flow challenges, analyst consensus remains unanimously bullish with 3 buy ratings.
The outlook hinges on successful execution of growth initiatives in neuro drug delivery and regulatory progress with partners, though high valuation multiples and persistent losses pose significant risks. Near-term catalysts include Q3 2026 earnings and partner developments, but investors face volatility from operational cash burn and competitive pressures.
Trailing returns across standard periods
ARKQ is an actively managed ETF that invests in autonomous technology and robotics. It focuses on disruptive innovations like autonomous mobility, electric vehicles, 3D printing, and energy storage, with holdings such as Tesla and Teradyne.
Read more on ARKQ →ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →